Ticker
CNCR
Asset Class
Equity
Assets Under Management
6.95M
Issuer
Range Cancer
Expense Ratio
79.00%
Inception Date
13-10-2015
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million.
Loading chart…